Bousch J, Beyersdorf C, Schultz K, Windolf J, Suschek C, Maus U
Int J Mol Sci. 2024; 25(22).
PMID: 39596421
PMC: 11594863.
DOI: 10.3390/ijms252212358.
Sun L, Chen J, Li L, Li L
PeerJ. 2024; 12:e18068.
PMID: 39308804
PMC: 11416762.
DOI: 10.7717/peerj.18068.
Sudha S, Upmanyu A, Saraswat D, Singh M
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):135-146.
PMID: 39136739
DOI: 10.1007/s00210-024-03351-w.
Jimenez-Ortega R, Ortega-Melendez A, Patino N, Rivera-Paredez B, Hidalgo-Bravo A, Velazquez-Cruz R
Biology (Basel). 2024; 13(7).
PMID: 39056698
PMC: 11273958.
DOI: 10.3390/biology13070505.
Kikyo N
Int J Mol Sci. 2024; 25(9).
PMID: 38731934
PMC: 11083221.
DOI: 10.3390/ijms25094717.
Recent advances in senescence-associated secretory phenotype and osteoporosis.
Fan H, Qiao Z, Li J, Shang G, Shang C, Chen S
Heliyon. 2024; 10(4):e25538.
PMID: 38375248
PMC: 10875379.
DOI: 10.1016/j.heliyon.2024.e25538.
Consequences of Aging on Bone.
Zhang L, Guan Q, Wang Z, Feng J, Zou J, Gao B
Aging Dis. 2023; 15(6):2417-2452.
PMID: 38029404
PMC: 11567267.
DOI: 10.14336/AD.2023.1115.
Bone repair and key signalling pathways for cell-based bone regenerative therapy: A review.
Nasir N, Arifin N, Noordin K, Yusop N
J Taibah Univ Med Sci. 2023; 18(6):1350-1363.
PMID: 37305024
PMC: 10248876.
DOI: 10.1016/j.jtumed.2023.05.015.
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation.
Flegel J, Shaaban S, Jia Z, Schulte B, Lian Y, Krzyzanowski A
J Med Chem. 2022; 65(24):16268-16289.
PMID: 36459434
PMC: 9791665.
DOI: 10.1021/acs.jmedchem.2c00956.
Therapeutic Treatments for Osteoporosis-Which Combination of Pills Is the Best among the Bad?.
Tonk C, Shoushrah S, Babczyk P, El Khaldi-Hansen B, Schulze M, Herten M
Int J Mol Sci. 2022; 23(3).
PMID: 35163315
PMC: 8836178.
DOI: 10.3390/ijms23031393.
Research progress on the hedgehog signalling pathway in regulating bone formation and homeostasis.
Zhou H, Zhang L, Chen Y, Zhu C, Chen F, Li A
Cell Prolif. 2021; 55(1):e13162.
PMID: 34918401
PMC: 8780935.
DOI: 10.1111/cpr.13162.
Mesenchymal Stem Cells, Bioactive Factors, and Scaffolds in Bone Repair: From Research Perspectives to Clinical Practice.
Stamnitz S, Klimczak A
Cells. 2021; 10(8).
PMID: 34440694
PMC: 8392210.
DOI: 10.3390/cells10081925.
PP2A in LepR+ mesenchymal stem cells contributes to embryonic and postnatal endochondral ossification through Runx2 dephosphorylation.
Yen Y, Chien M, Wu P, Hung S
Commun Biol. 2021; 4(1):658.
PMID: 34079065
PMC: 8172534.
DOI: 10.1038/s42003-021-02175-1.
The Role of Adipose Stem Cells in Bone Regeneration and Bone Tissue Engineering.
Mende W, Gotzl R, Kubo Y, Pufe T, Ruhl T, Beier J
Cells. 2021; 10(5).
PMID: 33919377
PMC: 8143357.
DOI: 10.3390/cells10050975.
Andrographolide promotes proliferative and osteogenic potentials of human placenta-derived mesenchymal stem cells through the activation of Wnt/β-catenin signaling.
Phunikom N, Boonmuen N, Kheolamai P, Suksen K, Manochantr S, Tantrawatpan C
Stem Cell Res Ther. 2021; 12(1):241.
PMID: 33853681
PMC: 8048284.
DOI: 10.1186/s13287-021-02312-x.
Regulation of Osteoblast Differentiation by Cytokine Networks.
Amarasekara D, Kim S, Rho J
Int J Mol Sci. 2021; 22(6).
PMID: 33799644
PMC: 7998677.
DOI: 10.3390/ijms22062851.
JAK2 Inhibition by Fedratinib Reduces Osteoblast Differentiation and Mineralisation of Human Mesenchymal Stem Cells.
Almuraikhi N, Alaskar H, Binhamdan S, Alotaibi A, Kassem M, Alfayez M
Molecules. 2021; 26(3).
PMID: 33503825
PMC: 7866227.
DOI: 10.3390/molecules26030606.
Effect of kirenol on the interaction between the WNT/β-Catenin and RUNX2/TCF/LEF1 pathways in fracture healing in vivo.
Karaman I, Gunay A, Yerer M, Demirpolat E, Dogan S, Yay A
Acta Orthop Traumatol Turc. 2020; 54(3):320-329.
PMID: 32544068
PMC: 7586779.
DOI: 10.5152/j.aott.2020.03.529.
Ixazomib Improves Bone Remodeling and Counteracts sonic Hedgehog signaling Inhibition Mediated by Myeloma Cells.
Tibullo D, Longo A, Vicario N, Romano A, Barbato A, Di Rosa M
Cancers (Basel). 2020; 12(2).
PMID: 32019102
PMC: 7073172.
DOI: 10.3390/cancers12020323.
Hedgehog Signaling Inhibition by Smoothened Antagonist BMS-833923 Reduces Osteoblast Differentiation and Ectopic Bone Formation of Human Skeletal (Mesenchymal) Stem Cells.
Almuraikhi N, Almasoud N, Binhamdan S, Younis G, Ali D, Manikandan M
Stem Cells Int. 2019; 2019:3435901.
PMID: 31871467
PMC: 6907053.
DOI: 10.1155/2019/3435901.